Rosetta Genomics: The Leader In MicroRNA Based Molecular Diagnostics $ROSG http://seekingalpha.com/a/18gg7 5 days ago
OncoSec Medical: Unique Electroporation Technology Delivering Cytokines To Target Cancer $ONCS http://seekingalpha.com/a/1842x Feb 28, 2014
Soligenix: Initiates New Programs To Target Melioidosis $SNGX http://seekingalpha.com/a/17ghf Feb 19, 2014
- innsbrooklad on The FDA Letter Won't Impact Atossa’S Business Much GrantHow about an apology. You said the FDA let...
- Herlina on GeoVax Is On Track To Advance Its HIV/AIDS Vaccine Programs In 2013 hello everyone, HIV CURE IS OUT BY PROPHET OLOR...
- jluscher on Arrowhead: There Is Still Room For Further Share Price Appreciation Thanks for the insight into how ARC-520 works.
- Grant Zeng on TKMR Is On Track To Advance TKM-Ebola Program sorry for being late responding to your questio...
- Grant Zeng on ATOS: Any Retreat In Share Price Should Provide A Good Entry Opportunity Sorry, I don't cover TROV.
- Advaxis (ADXS) Is On Track To Achieve 2012 Goals (4 Comments)
- TKMR Is On Track To Advance TKM-Ebola Program (4 Comments)
- ATOS: Any Retreat In Share Price Should Provide A Good Entry Opportunity (3 Comments)
- The FDA Letter Won't Impact Atossa’S Business Much (1 Comment)
- GeoVax Is On Track To Advance Its HIV/AIDS Vaccine Programs In 2013 (1 Comment)